The pharmacologic inhibition of FPR1 decreased T cell migration and infiltration into tumour microenvironments in most patients with locally advanced rectal cancer harbouring the CC genotype (E346A) of FPR1 (Chiang et al., 2021), highlighting it as an independent predictor. The gene discussed is FPR1; the disease is rectal cancer.